Tofacitinib in Down Syndrome
Conditions: Down Syndrome; Alopecia; Atopic Dermatitis/Eczema; Hidradenitis Suppurativa; Vitiligo; Psoriasis Intervention: Drug: Tofacitinib Sponsors: University of Colorado, Denver; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alopecia | Arthritis | Dermatitis | Dermatology | Down's Syndrome | Eczema | Psoriasis | Research | Rheumatology | Skin | Vitiligo